Axplora, a leading partner to Pharma companies and Biotechs for complex APIs, is pleased to announce a €8 million investment to expand capacity for antibody drug conjugate payload manufacturing at its Le Mans site (France), to deliver life-changing cancer treatments for patients.

This investment creates a new production suite for antibody drug conjugate payload manufacturing, to enable innovative pharmaceutical partners to develop the next generation of targeted therapies in oncology. This new suite will allow us to produce various payloads at kilogram scale to secure the supply of API for our customers. It has been designed to operate over a wide range of process conditions with best-in-class process equipment and containment technology. In addition, at least 15 new positions will be created to support the site in this ambitious project that will help improve patients’ lives.

“This increased capacity is the result of our long-term strategy of growing in a sustainable manner, with the commitment to provide more efficient and optimized manufacturing processes to secure the supply chain of our customers”, says Rachel De Luca, Site Director in Le Mans. “We are proud to develop tomorrow’s anticancer drugs to treat patients and confident that this investment will open up new opportunities to fight against cancer together with agility and reliability”.

Comments (0)

    Attach images by dragging & dropping or by selecting them.
    The maximum file size for uploads is 10MB. Only gif,jpg,png files are allowed.
     
    The maximum number of 3 allowed files to upload has been reached. If you want to upload more files you have to delete one of the existing uploaded files first.
    The maximum number of 3 allowed files to upload has been reached. If you want to upload more files you have to delete one of the existing uploaded files first.
    Posting as

    Comments powered by CComment